drugset

drugset / Trial / NCT01098578

Floseal Treatment for Posterior Epistaxis Study

NCT01098578 ↗

Completed 20 enrolled Ottawa Hospital Research Institute

NaSingle-groupOpen-labelTreatment

Summary

Effectiveness of Floseal for the treatment of posterior epistaxis.

Timeline

Start: 2010-04
Primary completion: 2011-11
Completion: 2011-11

Publications

Kilty SJ, Al-Hajry M, Al-Mutairi D, Bonaparte JP, Duval M, Hwang E, Tse D. Prospective clinical trial of gelatin-thrombin matrix as first line treatment of posterior epistaxis. Laryngoscope. 2014 Jan;124(1):38-42. doi: 10.1002/lary.24240. Epub 2013 Jun 28.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Floseal	Other / unclassified	—	—

Indications

No indication recorded.